Christiane Moecklinghoff

1.1k total citations
34 papers, 728 citations indexed

About

Christiane Moecklinghoff is a scholar working on Infectious Diseases, Virology and Emergency Medicine. According to data from OpenAlex, Christiane Moecklinghoff has authored 34 papers receiving a total of 728 indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Infectious Diseases, 27 papers in Virology and 12 papers in Emergency Medicine. Recurrent topics in Christiane Moecklinghoff's work include HIV/AIDS drug development and treatment (29 papers), HIV Research and Treatment (27 papers) and HIV/AIDS Research and Interventions (16 papers). Christiane Moecklinghoff is often cited by papers focused on HIV/AIDS drug development and treatment (29 papers), HIV Research and Treatment (27 papers) and HIV/AIDS Research and Interventions (16 papers). Christiane Moecklinghoff collaborates with scholars based in Germany, United Kingdom and Netherlands. Christiane Moecklinghoff's co-authors include José Ramón Arribas, Yvon van Delft, Andrew Hill, Nathan Clumeck, Mark Nelson, Andrew Hill, Federico Pulido, Andrzéj Horban, Jan Gerstoft and Thomas Stark and has published in prestigious journals such as PLoS ONE, The Journal of Infectious Diseases and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Christiane Moecklinghoff

33 papers receiving 716 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Christiane Moecklinghoff Germany 14 592 492 258 103 64 34 728
Natascia Sala Italy 9 316 0.5× 250 0.5× 215 0.8× 112 1.1× 18 0.3× 12 480
Ei Kinai Japan 12 352 0.6× 137 0.3× 241 0.9× 122 1.2× 20 0.3× 39 473
Anna Danise Italy 13 382 0.6× 289 0.6× 104 0.4× 128 1.2× 13 0.2× 24 504
Martin Gartland United Kingdom 11 794 1.3× 634 1.3× 262 1.0× 117 1.1× 13 0.2× 19 866
Kati Vandermeulen Belgium 12 651 1.1× 480 1.0× 177 0.7× 133 1.3× 7 0.1× 19 713
José Valdez Madruga Brazil 7 775 1.3× 600 1.2× 154 0.6× 181 1.8× 11 0.2× 11 829
L Caggese Italy 8 461 0.8× 318 0.6× 115 0.4× 150 1.5× 34 0.5× 9 597
Ezra Naman Tanzania 9 367 0.6× 236 0.5× 143 0.6× 136 1.3× 14 0.2× 11 478
Cristina Mussini Italy 11 336 0.6× 229 0.5× 112 0.4× 184 1.8× 21 0.3× 27 484
Roland Landman France 16 815 1.4× 541 1.1× 152 0.6× 242 2.3× 7 0.1× 63 917

Countries citing papers authored by Christiane Moecklinghoff

Since Specialization
Citations

This map shows the geographic impact of Christiane Moecklinghoff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christiane Moecklinghoff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christiane Moecklinghoff more than expected).

Fields of papers citing papers by Christiane Moecklinghoff

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christiane Moecklinghoff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christiane Moecklinghoff. The network helps show where Christiane Moecklinghoff may publish in the future.

Co-authorship network of co-authors of Christiane Moecklinghoff

This figure shows the co-authorship network connecting the top 25 collaborators of Christiane Moecklinghoff. A scholar is included among the top collaborators of Christiane Moecklinghoff based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christiane Moecklinghoff. Christiane Moecklinghoff is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Menon, Sonia, Neha Agarwal, Jorne Lionel Biccler, et al.. (2023). Geographic and Population Distributions of Human Immunodeficiency Virus (HIV)–1 and HIV-2 Circulating Subtypes: A Systematic Literature Review and Meta-analysis (2010–2021). The Journal of Infectious Diseases. 228(11). 1583–1591. 38 indexed citations
2.
Opsomer, Magda, Dessislava I. Dimitrova, Simon Vanveggel, et al.. (2018). Evaluation of Cardiovascular Disease Risk in HIV-1–Infected Patients Treated with Darunavir. Drugs in R&D. 18(3). 199–210. 9 indexed citations
3.
Clay, Patrick G., et al.. (2018). A meta-analysis comparing 48-week treatment outcomes of single and multi-tablet antiretroviral regimens for the treatment of people living with HIV. AIDS Research and Therapy. 15(1). 17–17. 44 indexed citations
4.
Antinori, Andrea, Amanda Clarke, José Ramón Arribas, et al.. (2015). Week 48 efficacy and central nervous system analysis of darunavir/ritonavir monotherapy versus darunavir/ritonavir with two nucleoside analogues. AIDS. 29(14). 1811–1820. 28 indexed citations
5.
Guaraldi, Giovanni, et al.. (2015). Morbidity in older HIV-infected patients: impact of long-term antiretroviral use.. PubMed. 16(2). 75–89. 45 indexed citations
6.
Clarke, Amanda, et al.. (2014). Analysis of neurocognitive function and CNS endpoints in the PROTEA trial: darunavir/ritonavir with or without nucleoside analogues. Journal of the International AIDS Society. 17(4S3). 19526–19526. 9 indexed citations
7.
8.
Antinori, Andrea, José Ramón Arribas, Jan Fehr, et al.. (2014). The PROTEA trial: darunavir/ritonavir with or without nucleoside analogues, for patients with HIV‐1 RNA below 50 copies/mL. Journal of the International AIDS Society. 17(4S3). 19525–19525. 15 indexed citations
9.
Powderly, William G., Andrew Hill, & Christiane Moecklinghoff. (2014). Is There a Higher Risk of CNS Adverse Events for PI Monotherapy Versus Triple Therapy? A Review of Results From Randomized Clinical Trials. HIV Clinical Trials. 15(3). 79–86. 5 indexed citations
10.
Nelson, Mark, Andrew Hill, Yvon van Delft, & Christiane Moecklinghoff. (2014). Etravirine as a Switching Option for Patients with HIV RNA Suppression: A Review of Recent Trials. AIDS Research and Treatment. 2014. 1–7. 6 indexed citations
11.
Girard, Pierre‐Marie, et al.. (2013). Can we stop CD4+ testing in patients with HIV-1 RNA suppression on antiretroviral treatment?. AIDS. 27(17). 2759–2763. 27 indexed citations
12.
Geretti, Anna María, José Ramón Arribas, Erkki Lathouwers, et al.. (2013). Dynamics of Cellular HIV-1 DNA Levels Over 144 Weeks of Darunavir/Ritonavir Monotherapy Versus Triple Therapy in the MONET Trial. HIV Clinical Trials. 14(1). 45–50. 24 indexed citations
13.
Stephan, Christoph, Andrew Hill, W. A. Sawyer, Yvon van Delft, & Christiane Moecklinghoff. (2012). Impact of baseline HIV‐1 RNA levels on initial highly active antiretroviral therapy outcome: a meta‐analysis of 12,370 patients in 21 clinical trials*. HIV Medicine. 14(5). 284–292. 22 indexed citations
14.
15.
Clumeck, Nathan, Dénes Bánhegyi, Wolfgang Schmidt, et al.. (2011). 96 week results from the MONET trial: a randomized comparison of darunavir/ritonavir with versus without nucleoside analogues, for patients with HIV RNA <50 copies/mL at baseline. Journal of Antimicrobial Chemotherapy. 66(8). 1878–1885. 41 indexed citations
16.
Fox, Julie, et al.. (2010). Improvement in Vitamin D Deficiency Following Antiretroviral Regime Change: Results from the MONET Trial. AIDS Research and Human Retroviruses. 27(1). 29–34. 69 indexed citations
17.
18.
Winston, Alan, Gerd Fätkenheuer, José Ramón Arribas, et al.. (2010). Neuropsychiatric Adverse Events With Ritonavir-Boosted Darunavir Monotherapy in HIV-Infected Individuals: A Randomised Prospective Study. HIV Clinical Trials. 11(3). 163–169. 13 indexed citations
19.
Arribas, José Ramón, Andrzéj Horban, Jan Gerstoft, et al.. (2009). The MONET trial: darunavir/ritonavir with or without nucleoside analogues, for patients with HIV RNA below 50 copies/ml. AIDS. 24(2). 223–230. 140 indexed citations
20.
Stocker, Hartmut, Charlotte Kloft, Nele Plock, et al.. (2006). Pharmacokinetics of Enfuvirtide in Patients Treated in Typical Routine Clinical Settings. Antimicrobial Agents and Chemotherapy. 50(2). 667–673. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Natascia Sala Breakdown of academic impact, for papers by Ei Kinai Breakdown of academic impact, for papers by Anna Danise Breakdown of academic impact, for papers by Martin Gartland Breakdown of academic impact, for papers by Kati Vandermeulen Breakdown of academic impact, for papers by José Valdez Madruga Breakdown of academic impact, for papers by L Caggese Breakdown of academic impact, for papers by Ezra Naman Breakdown of academic impact, for papers by Cristina Mussini Breakdown of academic impact, for papers by Roland Landman
Rankless by CCL
2026